ArticleOncology letters2020

Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical setting.

Aya Nakaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.